WY-14643 (Pirinixic Acid): Applied Workflows in Metabolic Re
2026-07-22
WY-14643 (Pirinixic Acid) stands out as a robust tool for dissecting PPARα-driven metabolic and inflammatory pathways, offering reproducible controls in both cellular and animal models. This article translates multiomics insights and recent workflow advances into actionable protocols, troubleshooting guidance, and next-generation applications for metabolic disorder research.
Berberine and Evodiamine Modulate GERD via TAS2R38/TRPV1 Pat
2026-07-22
This study reveals that berberine and evodiamine synergistically alleviate gastroesophageal reflux disease (GERD) by targeting bitter taste receptor TAS2R38 and TRPV1, regulating MAPK/NF-κB signaling, and affecting macrophage polarization. The findings highlight new molecular targets for GERD intervention and provide mechanistic insights into the anti-inflammatory effects of these bioactive compounds.
Ro 3306 (SKU A8885): Reliable CDK1 Inhibitor for G2/M Contro
2026-07-21
This article addresses real-world laboratory challenges in cell cycle synchronization and DNA repair research, illustrating how Ro 3306 (SKU A8885) achieves precise, reproducible G2/M phase arrest. Scenario-driven Q&A blocks offer data-backed insights for protocol optimization, assay compatibility, and vendor reliability, supporting biomedical researchers in selecting Ro 3306 as a validated, trustworthy CDK1 inhibitor.
KPT330 Enhances CRISPR-Cas9 Precision via mRNA Nuclear Expor
2026-07-21
The reference study demonstrates that KPT330, a selective inhibitor of nuclear export (SINE), improves the specificity of CRISPR-Cas9 genome and base editing by indirectly modulating the nuclear export of Cas9 mRNA rather than directly inhibiting Cas9 protein. This finding introduces a novel strategy for reducing off-target effects in genome editing workflows and broadens the molecular toolbox for precision genome engineering.
Polybrene: Mechanistic Leverage for Next-Gen Gene Delivery
2026-07-20
This article explores how Polybrene (Hexadimethrine Bromide) 10 mg/mL from APExBIO redefines precision gene delivery in translational research. Integrating new mitochondrial metabolism insights, it provides actionable guidance on leveraging Polybrene for viral transduction and advanced DNA transfection, while critically evaluating its mechanistic basis, protocol optimization, and clinical translation.
Live-Dead Cell Staining Kit I: Optimizing Mammalian Cell Ass
2026-07-20
Harness the Live-Dead Cell Staining Kit I (Calcein AM/PI) to streamline viability and cytotoxicity workflows for mammalian cell research. Discover protocol refinements, troubleshooting strategies, and how recent breakthroughs in cancer research translate to robust, reproducible live/dead cell detection.
Hydroxychloroquine Sulfate: Technical Use in Autoimmune Dise
2026-07-19
Hydroxychloroquine Sulfate (SKU B4874) is a quinoline-based inhibitor optimized for modulating autophagy and toll-like receptor (TLR7/9) signaling in autoimmune disease research workflows, particularly those modeling systemic lupus erythematosus and rheumatoid arthritis. It is specifically suited to aqueous-based, short-term protocols and should not be used in procedures requiring organic solvent solubility or long-term storage of stock solutions.
Gap19: Selective Connexin 43 Hemichannel Blocker in Neuropro
2026-07-18
Gap19, a highly selective connexin 43 hemichannel blocker, empowers researchers to dissect neuroglial and immune signaling with unmatched precision. Its unique mechanism and robust solubility enable advanced studies in neuroprotection, macrophage polarization, and ischemia models.
Trelagliptin Succinate: Bridging Diabetes and Bone Health
2026-07-17
Explore the mechanistic and translational potential of Trelagliptin succinate (SYR-472 succinate), a long-acting DPP-4 inhibitor, in type 2 diabetes and osteoporosis research. This thought-leadership article synthesizes emerging evidence of its role in osteoblastic differentiation, provides strategic protocol guidance, and highlights how APExBIO’s high-purity Trelagliptin succinate accelerates innovative workflows beyond glycemic control.
L-Alanyl-L-Glutamine: Technical Guide for GI Barrier Researc
2026-07-17
L-Alanyl-L-Glutamine (SKU B8228) addresses the demand for a stable, water-soluble L-Ala-L-Gln dipeptide that supports intestinal barrier function and mucosal integrity in gastrointestinal research. This product is not suitable for protocols requiring solubility in DMSO or ethanol. For workflows needing reproducibility and high-purity supplementation in aqueous systems, it is a preferred option.
Treponema pallidum Triggers Mitochondrial Apoptosis in Hepat
2026-07-16
This study elucidates how Treponema pallidum drives intrinsic apoptosis in hepatocytes through a mechanism involving mitochondrial dysfunction, reactive oxygen species (ROS) accumulation, and cardiolipin peroxidation. The findings deepen our understanding of syphilis-associated liver pathology and highlight mechanistic connections between bacterial infection, mitochondrial damage, and cell death.
Platycodin D Induces Apoptosis in NSCLC via RFC4-Notch Axis
2026-07-16
This study leverages multidimensional proteomics to reveal that Platycodin D directly targets RFC4, leading to Notch signaling inhibition and apoptosis in non-small cell lung cancer (NSCLC) cells. The findings clarify Platycodin D's molecular mechanism of action and highlight novel intervention points for epigenetic and protein degradation-based cancer therapies.
Evaluating Drug Responses in Cancer: Advances in In Vitro Me
2026-07-15
Schwartz's dissertation systematically redefines in vitro evaluation of anticancer drug responses by distinguishing between proliferation arrest and cell death metrics. This provides a more mechanistic basis for interpreting drug efficacy, with broad implications for preclinical research and translational oncology.
Romidepsin (FK228) Applied: HDAC Inhibition in Cancer Assays
2026-07-15
Romidepsin (FK228) stands out as a selective HDAC inhibitor enabling advanced epigenetic modulation and spliceosome-targeted workflows in cancer research. This article delivers actionable protocol enhancements, troubleshooting strategies, and a translation of the latest reference findings into applied assay design.
Angiotensin 1/2 (2-7): Precision Peptide for RAS Pathway Inn
2026-07-14
Explore how Angiotensin 1/2 (2-7) advances blood pressure regulation research and RAS pathway interrogation. This in-depth article unveils assay insights and novel implications for cardiovascular and viral studies using this high-purity peptide.
459 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page